Banzel (rufinamide) (Banzel 01)
Banzel Tablet, Film Coated
Product Images NDC 62856-582
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Banzel (NDC 62856-582). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Eisai Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Tablet Imprint (Banzel 02)
Figure A (Banzel 03)
Figure B (Banzel 04)
Figure C (Banzel 05)
The text is readable but it is too short to provide a useful description. It simply states "bottle adapter".*
Figure D (Banzel 06)
Figure E (Banzel 07)
Figure F (Banzel 08)
Figure G (Banzel 09)
Figure H (Banzel 0a)
Figure I (Banzel 0b)
Figure J (Banzel 0c)
Figure K (Banzel 0d)
Principal Display Panelndc 62856-582-04banzel® (rufinamide) Tablets200 mg4 Tablets (Banzel 0e)
Store BANZEL medication at room temperature of 25°C (77°F) and ensure it is protected from moisture. The medication should not be exposed to temperatures below 15°C (GO°F) or above 30°C (86°F). After opening, replace the cap securely. Detailed instructions on its dosage and use can be found in the accompanying prescribing information. This is a prescription-only medication, and the medication guide provided must be dispensed with the bottle. The given batch comprises 120 tablets of 200 mg of rufinamide. The lot number, expiration date, and serialization area are also provided.*
Principal Display Panelndc 62856-582-52banzel® (rufinamide) Tablets200 mg120 Tablets (Banzel 0f)
This is a label for BANZEL tablets, containing 400mg rufinamide each. It indicates that the tablets should be stored at a temperature between 15°C-30°C (69°F-86°F), protected from moisture, and the cap should be replaced after opening. There is some dosage and use information, which should be reviewed with the accompanying prescribing information. The label includes a lot number, expiration date, and serialization area. It also notes that the medication guide provided with the bottle should be dispensed.*
Principal Display Panelndc 62856-583-14banzel®(rufinamide) Tablets400 mg14 Tablets (Banzel 10)
This is a description of Banzel, an oral suspension medication used for treatment purposes. It contains rufinamide and a concentration of 40mg/mL. The medication should be shaken before use, stored at room temperature, and should be discarded within 90 days after opening. The prescription information for dosage and use should be consulted.*
Principal Display Panelndc 62856-583-52banzel®(rufinamide) Tablets400 mg120 Tablets (Banzel 11)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
